SynthesisAlpha psychiatry2026
Effectiveness of Computerized Cognitive Remediation Therapy on Executive Functions and Clinical Symptoms in Children and Adolescents With ADHD: A Meta-Analysis of Randomized Controlled Trials.
Synthesis in Alpha psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This meta-analysis of randomized clinical trials (RCTs) aimed to determine whether computer-assisted cognitive remediation therapy (CCRT) is a feasible adjunctive treatment to improve executive function and clinical symptoms in adolescents and children with attention deficit hyperactivity disorder (ADHD). Methods: We systematically searched 9 English and Chinese databases from database inception until May 2025. Randomized controlled trials investigating CCRT in children and adolescents with ADHD were collected. The risk of bias was assessed using the Cochrane Collaboration's tool for assessing risk of bias (RoB 2.0) and the Jadad Scale. Standardized mean differences in post-intervention data were calculated using RevMan 5.4 software. This study adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and was registered on the International Prospective Register of Systematic Reviews (PROSPERO) platform. Results: This review included 17 RCTs comprising 1087 cases. In the CCRT intervention groups, there was a significant decrease in overall executive function (standardized mean difference (SMD) = -0.23; 95% CI = [-0.45, -0.01]; Conclusion: CCRT played an important role in improving specific executive functions and attention symptoms in children and adolescents with ADHD. However, high-quality research is needed to validate these preliminary findings. The PROSPERO Registration: CRD42024619958, https://www.crd.york.ac.uk/PROSPERO/view/CRD42024619958.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.